Literature DB >> 2033656

Species-specific diversity among simian immunodeficiency viruses from African green monkeys.

J S Allan1, M Short, M E Taylor, S Su, V M Hirsch, P R Johnson, G M Shaw, B H Hahn.   

Abstract

The prevalence, natural history, and genetic characteristics of simian immunodeficiency virus (SIV) infections in most feral African monkey species are presently unknown, yet this information is essential to elucidate their origin and relationship to other simian and human immunodeficiency viruses. In this study, a combination of classical and molecular approaches were used to identify and characterize SIV isolates from West African green monkeys (Cercopithecus sabaeus) (SIVagm isolates). Four SIVagm viruses from wild-caught West African green monkeys were isolated and analyzed biologically and molecularly. Amplification, cloning, and sequencing of a 279-bp polymerase fragment directly from uncultured peripheral blood mononuclear cells was facilitated by the use of nested polymerase chain reaction. The results indicated that West African green monkeys are naturally infected with SIVs which are closely related to East African SIVagm isolates. However, structural, antigenic, and genetic differences were observed which strongly suggest that the West African green monkey viruses comprise a phylogenetically distinct subgroup of SIVagm. These findings support our previous hypothesis that SIVagm viruses may have evolved and diverged coincident with the evolution and divergence of their African green monkey host. In addition, this study describes a polymerase chain reaction-based approach that allows the identification and molecular analysis of divergent SIV strains directly from primary monkey tissue. This approach, which does not depend on virus isolation methods, should facilitate future studies aimed at elucidating the origins and natural history of SIVs in feral African green monkey populations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033656      PMCID: PMC240900     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

2.  Seroepidemiologic survey of captive Old-World primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys).

Authors:  L J Lowenstine; N C Pedersen; J Higgins; K C Pallis; A Uyeda; P Marx; N W Lerche; R J Munn; M B Gardner
Journal:  Int J Cancer       Date:  1986-10-15       Impact factor: 7.396

3.  Macrophage-HIV interaction: viral isolation and target cell tropism.

Authors:  H E Gendelman; L M Baca; H Husayni; J A Turpin; D Skillman; D C Kalter; J M Orenstein; D L Hoover; M S Meltzer
Journal:  AIDS       Date:  1990-03       Impact factor: 4.177

4.  Antibodies to simian immunodeficiency virus in African green monkeys in Africa in 1957-62.

Authors:  R M Hendry; M A Wells; M A Phelan; A L Schneider; J S Epstein; G V Quinnan
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

5.  Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas.

Authors:  A F Gazdar; D N Carney; P A Bunn; E K Russell; E S Jaffe; G P Schechter; J G Guccion
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

6.  Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys.

Authors:  M Murphey-Corb; L N Martin; S R Rangan; G B Baskin; B J Gormus; R H Wolf; W A Andes; M West; R C Montelaro
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

7.  Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys).

Authors:  P N Fultz; H M McClure; D C Anderson; R B Swenson; R Anand; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.

Authors:  N L Letvin; M D Daniel; P K Sehgal; R C Desrosiers; R D Hunt; L M Waldron; J J MacKey; D K Schmidt; L V Chalifoux; N W King
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  81 in total

1.  Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains.

Authors:  A L Edinger; C Blanpain; K J Kunstman; S M Wolinsky; M Parmentier; R W Doms
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus.

Authors:  S Goldstein; I Ourmanov; C R Brown; B E Beer; W R Elkins; R Plishka; A Buckler-White; V M Hirsch
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade.

Authors:  Frederic Bibollet-Ruche; Elizabeth Bailes; Feng Gao; Xavier Pourrut; Katrina L Barlow; Jonathan P Clewley; Jason M Mwenda; Daudi K Langat; Gerald K Chege; Harold M McClure; Eitel Mpoudi-Ngole; Eric Delaporte; Martine Peeters; George M Shaw; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

5.  Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.

Authors:  S E Kuhmann; E J Platt; S L Kozak; D Kabat
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 6.  Nonpathogenic simian immunodeficiency virus infections.

Authors:  Nichole R Klatt; Guido Silvestri; Vanessa Hirsch
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

7.  Antagonism of SAMHD1 is actively maintained in natural infections of simian immunodeficiency virus.

Authors:  Chelsea J Spragg; Michael Emerman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

8.  High levels of viral replication contrast with only transient changes in CD4(+) and CD8(+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx.

Authors:  Richard Onanga; Christopher Kornfeld; Ivona Pandrea; Jerome Estaquier; Sandrine Souquière; Pierre Rouquet; Virginie Poaty Mavoungou; Olivier Bourry; Souleymane M'Boup; Françoise Barré-Sinoussi; François Simon; Cristian Apetrei; Pierre Roques; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Regulatory genes of simian immunodeficiency viruses from west African green monkeys (Cercopithecus aethiops sabaeus).

Authors:  V Jubier-Maurin; P Sarni-Manchado; F Veas; N Vidal; F Bibollet-Ruche; J P Durand; A Galat-Luong; G Cuny
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild.

Authors:  M J Jin; J Rogers; J E Phillips-Conroy; J S Allan; R C Desrosiers; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.